Latest Articles

Publication Date
MGST3 Promotes Endometriosis Progression by Suppressing Ferroptosis.

Endometriosis (EMs) is characterized by dysregulated persistence and enhanced invasiveness of ectopic endometrial cells. Current treatment strategies remain limited by high recurrence rates and considerable adverse effects. Although iron overload …

Published: June 3, 2026, midnight
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity - Nature

GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity Nature

Published: June 2, 2026, 3:03 p.m.
Raising awareness for ovarian, endometrial cancers | 11 TV Hill - WBAL-TV

Raising awareness for ovarian, endometrial cancers | 11 TV Hill WBAL-TV

Published: June 2, 2026, 1:07 p.m.
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - MSN

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer MSN

Published: June 2, 2026, 12:41 a.m.
UCA1 facilitates endometriosis progression through EIF4A3-mediated stabilization of E2F1 mRNA and enhanced glycolysis.

Long non-coding RNA Urothelial carcinoma-associated 1 (UCA1) is a pivotal regulator in the progression of endometriosis (EMs), yet its mechanistic role remains elusive. This study identified UCA1 as a factor …

Published: June 2, 2026, midnight
Endometrial BCL6 Expression and Reproductive Outcomes in Infertile Women: A Systematic Review.

Background/Objectives: Endometrial B-cell lymphoma 6 (BCL6) overexpression has been proposed as a marker of progesterone resistance, occult endometriosis, and endometrial dysfunction in infertile women. Its possible association with reproductive outcomes …

Published: June 2, 2026, midnight
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - Medical Xpress

Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer Medical Xpress

Published: June 1, 2026, 8 p.m.
Quivers officially cancer-free after 14-year endometrial fight, Stern says - NewsBytes

Quivers officially cancer-free after 14-year endometrial fight, Stern says NewsBytes

Published: June 1, 2026, 4:05 p.m.
Staying Silent Can Leave You at Risk for Endometrial Cancer - IslanderNews.com

Staying Silent Can Leave You at Risk for Endometrial Cancer IslanderNews.com

Published: June 1, 2026, 4:01 p.m.
Staying Silent Can Leave You at Risk for Endometrial Cancer - InsideNoVa.com

Staying Silent Can Leave You at Risk for Endometrial Cancer InsideNoVa.com

Published: June 1, 2026, 4:01 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!